TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Anadys Pharmaceuticals, Inc. Takeover Under Investor Investigation

  • If you purchased shares of Anadys Pharmaceuticals (NASDAQ: ANDS) prior to the announcement and currently hold those shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

San Diego, Oct. 17, 2011 (Shareholders Foundation) -- The announcement that Anadys Pharmaceuticals agreed to be acquired by Roche for $3.70 per NASDAQ:ANDS shares prompted an investigation on behalf of investors of Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) concerning whether the offer to acquire Anadys Pharmaceuticals, Inc. and the buyout process are unfair to investors of Anadys Ph...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)